Ayala Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AYLA and other ETFs, options, and stocks.

About AYLA

Ayala Pharmaceuticals, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers.

CEO

Roni Mamluk

CEORoni Mamluk

Employees

Employees35

Headquarters

Rehovot, Tel Aviv

HeadquartersRehovot, Tel Aviv

Founded

2017

Founded2017

Employees

Employees35

AYLA Key Statistics

Market cap

8.89M

Market cap8.89M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

57.18K

Average volume57.18K

High today

$0.60

High today$0.60

Low today

$0.55

Low today$0.55

Open price

$0.5987

Open price$0.5987

Volume

4.70K

Volume4.70K

52 Week high

$10.53

52 Week high$10.53

52 Week low

$0.51

52 Week low$0.51

AYLA Earnings

-$0.75

-$0.66

-$0.58

-$0.49

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

-$0.49 per share

Estimated-$0.49 per share

Actual

-$0.66 per share

Actual-$0.66 per share

Ayala Pharmaceuticals

Why Robinhood?

Ayala Pharmaceuticals, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. Show more

AYLA Key Statistics

Ayala Pharmaceuticals, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers.